A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression

被引:450
作者
Rovin, BH
Lu, L
Saxena, R
机构
[1] Ohio State Univ, Div Nephrol, Dept Med, Sch Med & Publ Hlth, Columbus, OH 43210 USA
[2] Ohio State Univ, Dept Pathol, Sch Med & Publ Hlth, Columbus, OH 43210 USA
关键词
D O I
10.1006/bbrc.1999.0796
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
novel polymorphisms in the distal regulatory region of the MCP-1 gene were identified by directly sequencing PCR amplified genomic DNA. These polymorphisms are located at positions -2518 (G or A) and -2076 (A or T) relative to the major transcriptional start site of the gene. To examine the effect of these polymorphisms on MCP-1 transcription, polymorphic variants of the MCP-1 distal regulatory region were placed upstream of a luciferase reporter gene and transfected into A172 cells. IL-1 beta-induced luciferase activity was significantly greater from cells transfected with constructs containing G; at position -2518. The polymorphism at -2076 did not affect MCP-1 transcription. IL-1 beta-treated peripheral blood mononuclear cells from individuals heterozygous or homozygous for G at -2518 produced more MCP-1 than cells from individuals homozygous for A at -2518. These data identify a polymorphism in the MCP-1 distal regulatory region that affects the level of MCP-1 expression in response to an inflammatory stimulus. (C) 1999 Academic Press.
引用
收藏
页码:344 / 348
页数:5
相关论文
共 28 条
[1]   EXPRESSION OF MONOCYTE CHEMOATTRACTANT PROTEIN-1 MESSENGER-RNA IN HUMAN IDIOPATHIC PULMONARY FIBROSIS [J].
ANTONIADES, HN ;
NEVILLEGOLDEN, J ;
GALANOPOULOS, T ;
KRADIN, RL ;
VALENTE, AJ ;
GRAVES, DT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (12) :5371-5375
[2]  
BIRMINGHAM DJ, 1994, J IMMUNOL, V153, P691
[3]   Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease [J].
Bouma, G ;
Crusius, JBA ;
Pool, MO ;
Kolkman, JJ ;
VonBlomberg, BME ;
Kostense, PJ ;
Giphart, MJ ;
Schreuder, GMT ;
Meuwissen, SGM ;
Pena, AS .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1996, 43 (04) :456-463
[4]   POLYMORPHISM IN TUMOR-NECROSIS-FACTOR GENES ASSOCIATED WITH MUCOCUTANEOUS LEISHMANIASIS [J].
CABRERA, M ;
SHAW, MA ;
SHARPLES, C ;
WILLIAMS, H ;
CASTES, M ;
CONVIT, J ;
BLACKWELL, JM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (05) :1259-1264
[5]  
Grandaliano G, 1996, J AM SOC NEPHROL, V7, P906
[6]   HERITABLE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II-ASSOCIATED DIFFERENCES IN PRODUCTION OF TUMOR NECROSIS FACTOR-ALPHA - RELEVANCE TO GENETIC PREDISPOSITION TO SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
JACOB, CO ;
FRONEK, Z ;
LEWIS, GD ;
KOO, M ;
HANSEN, JA ;
MCDEVITT, HO .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (03) :1233-1237
[7]   ENHANCED PRODUCTION OF MONOCYTE CHEMOATTRACTANT PROTEIN-1 IN RHEUMATOID-ARTHRITIS [J].
KOCH, AE ;
KUNKEL, SL ;
HARLOW, LA ;
JOHNSON, B ;
EVANOFF, HL ;
HAINES, GK ;
BURDICK, MD ;
POPE, RM ;
STRIETER, RM .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (03) :772-779
[8]   The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription [J].
Kroeger, KM ;
Carville, KS ;
Abraham, LJ .
MOLECULAR IMMUNOLOGY, 1997, 34 (05) :391-399
[9]  
Lazarus M, 1997, J RHEUMATOL, V24, P2314
[10]  
Marsh CB, 1997, J IMMUNOL, V158, P1078